Archives fda

by in
Entry Author Date Location
Shire Snaps up New York’s Foresight Bio in $300M Pink Eye Deal 08/03/15 New York
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
Synergy Hits Mark on Second Trial, Eyes Approval For Constipation Drug 07/30/15 New York
No Tumor Left Behind: FDA Clears NeuWave Software for Procedures 07/30/15 Wisconsin
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
Raleigh-Durham Roundup: Chimerix, vTv, Biotech Center, & More 07/27/15 Raleigh Durham
Beer Out as Struggling Aegerion Shuffles Leadership Ranks 07/27/15 Boston
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
Exact Sciences Raises $174M, Nearly Doubles War Chest For Diagnostics 07/23/15 Wisconsin
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
FDA Clears 2 New Propeller Health Devices That Track Respiratory Meds 07/22/15 Wisconsin
Alzheimer’s Drug Firm vTv Therapeutics Sets Terms for $125M IPO 07/20/15 Raleigh Durham
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
NephroGenex Aims to Raise $7.5M for Diabetic Nephropathy Drug 07/17/15 Raleigh Durham
West Coast Biotech Roundup: Receptos, ProNAi, Protagonist & More 07/16/15 San Diego
As Boomers Gray, Kegels Aren’t Just for Women Anymore 07/16/15 Texas
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past 07/15/15 Boston
With $36M Funding, Arivale Walks Line To Push Wellness Business 07/14/15 Seattle
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials 07/10/15 Boston
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
Green Park & Golf Brings Swedish Medtech “Cooling Cap” to Dallas 07/07/15 Texas
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors 07/07/15 Detroit
Chiasma Seeks $75 Million and FDA Approval for Acromegaly Orphan Drug 07/06/15 Boston
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis 07/02/15 Boston
XRpro Resurrects Icagen With Buy of Some Pfizer Ion Channel Assets 07/02/15 Boston
Page 1 of 46 next page »